Hepatitis News : Muscle Wasting Greatly Reduces Survival While Awaiting Liver Transplant
A Smart + Strong Site
Subscribe to:
Hep Magazine In Bulk
Hep Newsletter
Join Us:

Back to home » Hepatitis News » February 2012


February 28, 2012

Muscle Wasting Greatly Reduces Survival While Awaiting Liver Transplant

Health care providers need to be on the lookout for muscle wasting in their patients with advanced liver disease, particularly when assessing where they need to be placed on transplant lists, according to a new report published in Clinical Gastroenterology and Hepatology.

This conclusion comes from a study in which researchers at the University of Alberta, under the direction of Michael Sawyer, MD, reviewed the medical records of more than 100 patients who had cirrhosis and were placed on the national liver transplant list. Sawyer’s team found that those who were losing muscle were more likely to die while awaiting surgery.

These cirrhosis patients, the researchers found, were placed at a lower spot on the transplant list because they had a higher functioning liver and were seemingly less sick than others with the same condition, based on scoring systems health care providers commonly use today.

Sawyer’s group studied 112 patients with cirrhosis who were awaiting liver transplants at the University of Alberta Hospital and discovered 40 percent of them had muscle wasting or low muscle mass. Those with low muscle mass lived for about 19 months if they couldn’t get a transplant, while those with normal muscle mass lived for about 34 months without a liver transplant.

“Patients with cirrhosis who have low muscle mass are actually more sick than what current scoring systems are telling us, and many of them die while waiting on the liver transplant lists,” said Sawyer in an accompanying news announcement. “Patients with low muscle mass will get put on the list thinking they can wait for around three years, but really they can only wait for about one-and-a-half years.”

Sawyer adds: “Those in the medical field have been looking for better methods to assess patients with cirrhosis, and this may be that missing piece to the puzzle. If we can combine this measure of muscle mass with the current scoring system, it will provide a better way of predicting survival rates of patients awaiting liver transplants.”

Search: muscle, wasting, liver, cirrhosis, transplant, survival, mortality

Scroll down to comment on this story. Click here to visit the Hep Forums and ask questions about this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The Hep team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (2 total)

[Go to top]


Current Issue
Hep Stories
Services Directory
Conference News
Top Stories
Treatment News
Hep Exclusives
All About Hepatitis
• Hepatitis A
• Hepatitis B
• Hepatitis C
HCV/HIV Coinfection
Help Paying For Meds
Clinical Trials
Tell us what you think
Have you been diagnosed with liver fibrosis?

Hepatitis C Reader Survey
© 2015 Smart + Strong. All Rights Reserved. Terms of use and Your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.